Novo Nordisk A/S
NVO · NYQ · Financials · Verdict · News · Trade plan · Forecast · Analysts & technicals · Options · AI analysis
Price
40 USD
close · 30.10.2026 (America/New_York)
Change vs previous close
+2.2%
Close, 1Y: 30.10.2025 50.04 → 30.10.2026 40 (-20.1%), min 35.29, max 63.98
Data: partial
ADR: P/B and multiples by year unavailable (receipt ≠ share)
Valuation · Reporting currency: DKK
P/E
9.8
P/S
3.6
EV/EBITDA
—
FCF yield
+3.2%